In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GE’s Investment In Wuxi Pays Off

This article was originally published in PharmAsia News

Executive Summary

At a recent MOU signing ceremony between GE and the Wuxi government, GE China announced that its investment in the Yangtze river delta has shown results. GE Healthcare established GE Medical Systems (China) in Wuxi with $30 million in 2000, while GE Water & Process Technologies invested $17.6 million in setting up GE Betz Water & Process Chemicals (Wuxi) in 2004. GE Healthcare successfully acquired Wuxi Zhongyuan Medical Equipment in 2006 and named the company GE Healthcare Clinical System (Wuxi). The three companies greatly boost GE's health care R&D and water processing capability in China. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel